Elemental Iodine Or Iodine Compound Patents (Class 424/667)
  • Patent number: 9504255
    Abstract: The present invention relates to a physical antimicrobial method, which has the action of combating or inhibiting microorganisms when applied to the surface of human or animal body or an object. The method is safe for human body, and can prevent drug resistance caused by an antibacterial drug.
    Type: Grant
    Filed: July 16, 2013
    Date of Patent: November 29, 2016
    Assignee: NMS TECHNOLOGIES CO., LTD.
    Inventor: Youliang Cai
  • Publication number: 20150099011
    Abstract: A method of treating early papillomavirus infection of an orifice of a human or animal body including any canal associated with an orifice, comprising applying a viral inactivation agent to the orifice and/or canal in an amount effective to inactivate a portion of the virus infecting the orifice or canal. Apparatus is also disclosed.
    Type: Application
    Filed: December 11, 2014
    Publication date: April 9, 2015
    Inventor: Jenny Colleen McCloskey
  • Patent number: 8993001
    Abstract: Methods for treating feline hyperthyroidism comprising (1) administering to a feline an antithyroid agent in conjunction with feeding the feline a composition comprising from about 0.1 to less than about 1 mg/kg iodine or (2) feeding the feline a composition comprising from about 0.1 to less than about 1 mg/kg selenium on a dry matter basis.
    Type: Grant
    Filed: January 26, 2007
    Date of Patent: March 31, 2015
    Assignee: Hill's Pet Nutrition, Inc.
    Inventors: Karen Joy Wedekind, Dale Allen Fritsch, Chadwick Everett Dodd, Timothy Arthur Allen
  • Patent number: 8951578
    Abstract: A compound of all natural ingredients allows for treatment of infected, inflamed, and sore hooves without the need for wrapping the hoof with a diaper or vet wrap as is conventional. The compound is packable into the bottom of a hoof. A sugar base allows the compound to stick to the underside of a hoof and remain applied without the wrap. Epsom salts and iodine provide antiseptic and antimicrobial properties, and pine tar provides moisture balance within the hoof in addition to supplementing the stickiness of the compound. Applied compound may be covered with a piece of paper or cloth.
    Type: Grant
    Filed: November 16, 2011
    Date of Patent: February 10, 2015
    Inventor: Ashley Kehoe
  • Publication number: 20150030701
    Abstract: Disclosed are compositions and methods for antimicrobial use. The compositions contain a small antimicrobial agent and a permeabilizing agent. The antimicrobial compositions can be antifungal or antibacterial compositions.
    Type: Application
    Filed: March 13, 2013
    Publication date: January 29, 2015
    Applicant: Yale University
    Inventors: Ronald R. Breaker, Sanshu Li
  • Publication number: 20150017260
    Abstract: A nutritional supplement composition for treating nutritional deficiencies caused by a medical condition in subjects is disclosed. The present application further discloses a method of using a nutritional supplements composition for treating a subject with complications resulting from sickle cell anemia. The method comprises administering to a subject an effective amount of the nutritional supplement.
    Type: Application
    Filed: July 28, 2014
    Publication date: January 15, 2015
    Inventors: Jacqueline M. Hibbert, Jonathan K. Stiles, Kayellen Umeakunne, Hyacinth I. Hyacinth
  • Publication number: 20140356424
    Abstract: The present invention relates to the field of food and medicines for the treatment or alleviation of premenstrual syndrome (PMS), premenstrual dysphoric disorder (PMDD), premenopause, menopause and female hormonal disorders. A first embodiment relates to a composition containing vitamins, minerals and oils. Additionally, the invention comprises a pharmaceutical form, more specifically in the form of soft capsules (also known as gelatin) containing the composition of the invention. In particular, the compositions of the invention contain vitamins and minerals in sources compatible with the association of vegetable oils, preferably borage oil, evening primrose oil, or a mixture of two oils, wherein the soft capsule contains a liquid and oily core.
    Type: Application
    Filed: May 30, 2014
    Publication date: December 4, 2014
    Inventors: Wladia Möller VILAR, Thalita Piassa BARUFALDI, Silvana MASIERO, Rebecca Magalhães NADALUTI, Letícia Khater COVESI
  • Publication number: 20140348944
    Abstract: This invention relates to a “high lower alcohol content”(>40% v/v of a C1-4 alcohol) liquid composition able to be dispensed as a stable foam with the use of non-propellant foam dispensing devices from non-pressurized containers. The liquid compositions comprise an alcohol, C1-4 (>40% v/v), a silicone-based surfactant of at least 0.001% by weight to prepare a foamable composition, 0-10% w/w of additional minor components added to obtain the desired performance (a foamable composition), and the balance being purified water. The compositions may include emulsifier-emollients and moisturizers, secondary surfactants, foam stabilizers, fragrances, antimicrobial agents, other type of medicinal ingredients, and the like ingredients or additives or combinations thereof commonly added to alcohol gels or foams, aerosol compositions or to toiletries, cosmetics, pharmaceuticals and the like.
    Type: Application
    Filed: February 24, 2014
    Publication date: November 27, 2014
    Applicant: Deb Worldwide Healthcare Inc.
    Inventors: Maria Teresa Fernandez de Castro, Bruce Michael Koivisto, Francisco Munoz
  • Publication number: 20140271927
    Abstract: The present invention provides therapeutic and nutrient compositions comprising Alpha lipoic acid, gammalinolenic acid, chromium, selenium, and optionally iodine for the treatment of diabetic neuropaty. These compositions ameliorate the condition and symptoms associated with the complications of lack of triiodothyronine in the nucleus of target cells, in particular and the pathological effects of the vaso nervorum.
    Type: Application
    Filed: March 13, 2014
    Publication date: September 18, 2014
    Inventor: Agustin Andrade
  • Publication number: 20140271926
    Abstract: A method of treating neoplastic growth in a subject includes administering a glutamine synthetase (GS) inhibitor to the subject having neoplastic growth. A glutamine synthetase inhibitor may be administered in combination with thalidomide, lenalidomide and/or pomalidomide. Responsiveness to thalidomide, lenalidomide or pomalidomide therapy is determined by the expression levels of glutamine synthetase in neoplastic cells.
    Type: Application
    Filed: March 12, 2014
    Publication date: September 18, 2014
    Inventors: Thang V. Nguyen, Raymond J. Deshaies
  • Publication number: 20140271529
    Abstract: Disclosed herein are antifungal compositions and methods of using the same to treat secondary skin and nail infections.
    Type: Application
    Filed: March 13, 2014
    Publication date: September 18, 2014
    Applicant: ALC Therapeutics, LLC
    Inventors: Martin STOGNIEW, Robert ALONSO, Joseph CAPRIOTTI, Kara CAPRIOTTI, Stuart LESSIN
  • Publication number: 20140271925
    Abstract: A method and apparatus for producing aqueous iodine solutions to be used as a surface and aerosol disinfectant under continuous and dynamic flow conditions for medical applications comprises dissolving iodine into a first water flow thereby producing a concentrated aqueous iodine solution. The iodine solution is stored and then blended with a second water flow to produce a predetermined iodine disinfectant concentration of aqueous iodine. The disinfectant concentration is then stored and chemically adjusted to polarize to the species of iodine. The disinfectant concentration is then thermodynamically adjusted to maximize retention and disinfection variables. The iodine disinfectant is then ready to be used in an application requiring disinfection using iodine.
    Type: Application
    Filed: March 12, 2014
    Publication date: September 18, 2014
    Applicant: NEET Innovations, LLC
    Inventor: Terence F. MULLINS
  • Publication number: 20140271558
    Abstract: Beta glucan and fulvic acid can be combined in a dietary supplement as a partial substitute or complete replacement for blue green algae and/or brown seaweed and its derivatives. Beta glucans are widely available as derivatives of Brewer's yeast and fulvic acid is widely available as well. These supplements are not subject to the vagaries of weather-influence growing seasons as is the case with blue green algae and brown seaweed. When combined, beta glucan and fulvic acid can provide a less costly dietary supplement than blue green algae and brown seaweed and its derivatives such as fucoidan.
    Type: Application
    Filed: March 12, 2014
    Publication date: September 18, 2014
    Applicant: Cappellos, Inc.
    Inventor: John V. Cappello
  • Publication number: 20140234442
    Abstract: Disclosed is dental root canal filling (intracanal medicament) compositions that are effective against resistant root canal infections caused by Enterococcus faecalis and Vancomycin-resistant Enterococci.
    Type: Application
    Filed: September 17, 2012
    Publication date: August 21, 2014
    Inventor: Rajdeep S. Pavaskar
  • Publication number: 20140205559
    Abstract: Improvements in or relating to manually operated dispense heads for fluid containers
    Type: Application
    Filed: May 8, 2012
    Publication date: July 24, 2014
    Applicant: ALC THERAPEUTICS, LLC
    Inventors: Joseph Capriotti, Kara Capriotti
  • Publication number: 20140193371
    Abstract: A method for preventing and treating one or more disease states including the steps of altering the diet of an individual and then administering a drug to the individual. Plasma vitamin C level is reduced from a first level to a second level that is lower than the first level, such that a pharmacological response of the body of the individual to a drug at the first level is different from the pharmacological response of the body of said individual to the drug at the second level.
    Type: Application
    Filed: January 7, 2014
    Publication date: July 10, 2014
    Inventor: Harold Edward Siess
  • Patent number: 8753692
    Abstract: The present invention provides novel compositions comprising: (a) protamine sulfate and (b) benzalkonium chloride or a silver containing particle; or (a) sodium metaperiodate and (b) 5-fluorouracil or chlorhexidine and uses thereof for the preparation of devices, and in particular medical devices, susceptible to colonization by biofilm forming bacteria.
    Type: Grant
    Filed: January 22, 2010
    Date of Patent: June 17, 2014
    Assignee: Kane Biotech Inc.
    Inventors: Purushottam V. Gawande, Srinivasa Madhyastha, Karen Lovetri, Nandadeva Yakandawala, Gord Froehlich
  • Patent number: 8691290
    Abstract: A method for killing or substantially eradicating a pathogen in the upper respiratory tract of a mammal is disclosed. The method comprises generating molecular iodine (I2) in situ using an oxidant-reductant reaction with a minimum concentration of at least about 25 ppm of I2 and I2 comprises at least 40% of the total iodine atoms. A method for inhibiting superantigens using molecular iodine is also disclosed.
    Type: Grant
    Filed: October 15, 2012
    Date of Patent: April 8, 2014
    Assignee: Iogen LLC
    Inventors: Jack Howard Kessler, James Carlton Richards
  • Patent number: 8691286
    Abstract: A composition for dissolving or reducing the viscosity of sputum on a surface of a device includes an effective amount of glycerol and an effective amount of dextran sulfate in a saline solution. The effective amount of glycerol is between about 30-50% and the effective amount of dextran sulfate is between about 10-30%. The composition may further include an antimicrobial agent.
    Type: Grant
    Filed: January 26, 2010
    Date of Patent: April 8, 2014
    Assignee: Teleflex Medical Incorporated
    Inventors: Nisha Gupta, Erin Peters, Joel Rosenblatt
  • Patent number: 8679515
    Abstract: Contaminants are filtered from a fluid flow stream and the filter is regenerated by a process including steps of: providing a filter material comprising both carbon and potassium iodide; passing a contaminated fluid stream in contact with the filter material; adsorbing contaminants from the fluid stream onto surfaces in the filter material; passing an electric current through the filter material with adsorbed contaminant thereon; disassociating contaminant from the surfaces of the filter material; and removing disassociated contaminant from the filter material by carrying away the disassociated contaminant in a fluid flow mass. Separately, a stable, active iodine solution is also provided for numerous deodorizing and disinfecting applications.
    Type: Grant
    Filed: May 18, 2012
    Date of Patent: March 25, 2014
    Assignee: Biolargo Life Technologies, Inc.
    Inventors: Kenneth R. Code, Joseph Provenzano
  • Publication number: 20140044685
    Abstract: Nutritional compositions for maximizing muscle protein synthesis while minimizing the catabolism of muscle proteins and methods of using same are provided. In this manner, the nutritional compositions may provide for retention of lean body mass, which helps to avoid loss of independence and functionality, as well as to improve quality of life especially in the elderly at risk of sarcopenia and frailty. The nutritional compositions include ?-hydroxyisocaproic acid and citrulline. The composition may include other functional ingredients such as, but not limited to whey protein including whey protein micelles, prebiotic fibers, ?-keto-glutarate, eicosapentaenoic acid, L-carnitine, nucleotides, and amino acids. Methods of administering such nutritional products to individuals in need of same are also provided.
    Type: Application
    Filed: April 18, 2012
    Publication date: February 13, 2014
    Applicant: NESTEC S.A.
    Inventors: Norman Alan Greenberg, Denis Breuille, Zamzam Kabiry (Fariba) Roughead, Doug Bolster, Jennifer Mager
  • Patent number: 8642057
    Abstract: Antimicrobial solutions and delivery systems for them use liquid antimicrobial solutions with: at least 80% of total weight of a carrier liquid comprising water, alcohol or a mixture of water and alcohol; at least 0.0001% by weight of the solution of I2; at least 0.0001% by weight of CuSO4; and sufficient acid in the solution top provide a pH of less than 7.0. A buffering system is also preferable in the solution, and the solution may be provided directly as a liquid, as a spray, as a gel, imbibed and carried in a wipe, encapsulated solution, segregated droplets of solution (in carrying layers of particles, dispersed in a solid of gel carrier) and the like.
    Type: Grant
    Filed: November 30, 2011
    Date of Patent: February 4, 2014
    Assignee: Biolargo Life Technologies, Inc.
    Inventors: Kenneth R. Code, Joseph L. Provenzano, Richard D. Bickerstaff
  • Publication number: 20140030241
    Abstract: Nutritional compositions having dietary nucleotides, ?-3 fatty acids and citrulline are provided. The nutritional compositions may be formulated to improve T cell function, increase arginine availability in vivo, regulate myeloid-derived suppressor cells (“MDSC”), and decrease the risk and/or severity of infection after surgery or trauma. Methods of making, using and administering such nutritional compositions to individuals in need of same are also provided. Methods for modulating the affects of MDSC's are also provided.
    Type: Application
    Filed: March 15, 2012
    Publication date: January 30, 2014
    Applicant: NESTEC S.A.
    Inventor: Norman Alan Greenberg
  • Publication number: 20140023728
    Abstract: A iodine liquid soap dispenser having a reservoir containing an iodine solution. The dispenser has a head communicating with the reservoir capable of delivering the solution to the exterior of the reservoir in the form of foam. The solution comprises water, iodine and iodide, and contains iodine in a range of concentration between 0.35% and 0.05% by weight of the solution. The solution may also contain one or more of the following: an anionic surfactant, Hydrogen Iodide, glycerine, and sodium hydroxide.
    Type: Application
    Filed: July 20, 2012
    Publication date: January 23, 2014
    Inventor: David Ricketts, SR.
  • Publication number: 20140010881
    Abstract: Iodine-containing germicidal compositions are disclosed that remain physically stable for extended storage periods with little to no iodine complexing agent being present. The compositions employ a mixture of emollients, such as glycerin and ethoxylanolin, to create a composition that in certain embodiments presents a cloudy or emulsion-like appearance.
    Type: Application
    Filed: March 23, 2012
    Publication date: January 9, 2014
    Applicant: DELAVAL HOLDING AB
    Inventor: Mark Henderson
  • Publication number: 20140005616
    Abstract: Single layer and multi-layer anti-microbial wound care fabrics, gloves, sleeves, anklets, socks, finger cots, masks, and similar wound care articles are disclosed.
    Type: Application
    Filed: June 27, 2013
    Publication date: January 2, 2014
    Applicant: Ansell Limited
    Inventors: JEFFREY MORELAND, ROGER EUGENE HUCKFELDT, DION ROSS, ERIC THOMPSON, JAMIE ASHWORTH, MICHAEL ZEDALIS, ANTHONY B. LOPEZ
  • Patent number: 8574610
    Abstract: An article or material is applied to the environment of the body of an animal (including humans) to provide both absorbency and antimicrobial activity. The article or material may comprise a water absorbent material; and a composition that reacts with water to produce molecular iodine. The composition provides a local concentration (in the water) of at least 10 parts per million iodine in water carried by the material (that is actual water supported by the water absorbent material) when the material has 5% by weight of water present in the water absorbent. The material may be a flowable material, or the article may be diaper, sanitary pad, bandage, adhesive pad or wrap for an animal.
    Type: Grant
    Filed: January 10, 2011
    Date of Patent: November 5, 2013
    Assignee: Biolargo Life Technologies, Inc.
    Inventor: Kenneth R. Code
  • Publication number: 20130287865
    Abstract: Antimicrobial solutions and delivery systems for them use liquid antimicrobial solutions with: at least 80% of total weight of a carrier liquid comprising water, alcohol or a mixture of water and alcohol; at least 0.0001% by weight of the solution of I2; at least 0.0001% by weight of CuSO4; and sufficient acid in the solution top provide a pH of less than 7.0. A buffering system is also preferable in the solution, and the solution may be provided directly to wounds, burns or other skin damage as a liquid, as a spray or as a gel.
    Type: Application
    Filed: March 15, 2013
    Publication date: October 31, 2013
    Applicant: BIOLARGO LIFE TECHNOLOGIES, INC.
    Inventors: Kenneth R. Code, Joseph Provenzano, Richard D. Bickerstaff
  • Publication number: 20130259917
    Abstract: Antiseptic compounds that act as persistent and fast acting antiseptics and disinfectants. The base of these antiseptic actions is CaF2 as the persistent part, preventing the colonization of tissue and nonliving surfaces with microorganisms through the targeted on-demand release of fluorine ions. For fighting heavy contamination and invasion of transient microbes through new application of the solution, fast acting alcohols and toxic solutions have been added in small percentage. They act fast and evaporate fast, leaving the natural protection of skin undamaged and coated with a persistent antiseptic.
    Type: Application
    Filed: May 20, 2013
    Publication date: October 3, 2013
    Inventors: Fridolin Voegeli, Frank Flechsig, Thomas Flechsig
  • Publication number: 20130209582
    Abstract: To propose a health food or a drug, which comprises an iodine compound as a substitute for organic iodine and can exert a similar effect as organic iodine. To propose a method for producing a liquid to be used as a starting material for the aforesaid health food or drug. A health food and a drug each containing hydrogen iodide as the active ingredient. A method for producing a hydrogen iodide-containing solution, which comprises: an alkaline ion water preparation step for preparing alkaline ion water containing hydrogen peroxide; a sodium hydroxide production step for adding sodium to the alkaline ion water and thus producing sodium hydroxide; and a hydrogen iodide production step for, after the sodium hydroxide production step, adding iodine to the alkaline ion water and thus producing hydrogen iodide.
    Type: Application
    Filed: September 27, 2010
    Publication date: August 15, 2013
    Inventor: Kazuyoshi Sato
  • Publication number: 20130209581
    Abstract: The present invention relates to the use of iodinated activated charcoal, optionally in combination with a bromide salt, in treatment of one or more symptom(s) caused by depression, wherein said symptom(s) is/are selected from the group consisting depressive mood, emotional fatigue, mental fatigue which can be chronic, burnout, withdrawal from social situations, anxiety, concentration problems, unpleasant heart palpitations, irregular heart beats, a feeling of pressure in the chest, irritable bowel syndrome and sexual dysfunction.
    Type: Application
    Filed: June 21, 2011
    Publication date: August 15, 2013
    Applicant: PHARMALUNDENSIS AB
    Inventor: Staffan Skogvall
  • Publication number: 20130183277
    Abstract: Provided are compositions and methods for increasing patient CD4+ cell count while undergoing treatment for immune-mediated disease, cancer, heart disease, neurodegenerative disease, or infectious disease by administering to the patient a nutrient composition including, inter alia, alpha lipoic acid, acetyl L-carnitine, and N-acetyl-cysteine.
    Type: Application
    Filed: December 19, 2012
    Publication date: July 18, 2013
    Inventor: Jon D. Kaiser
  • Publication number: 20130122115
    Abstract: A specifically formulated composition comprised of Magnesium Sulfate (Epsom salt), Triodine-7 Solution (about 2% Iodine tincture, Potassium Iodide and Povidone Iodine), Arnica Montana 30x, and Pine Tar for the treatment of horse hoof soreness, Inflammation, and Infection (including abscesses). The formula contains specific amounts of each ingredient to pull out the infection while maintaining proper moisture balance in the hoof. This composition includes a sugar wax tackifier which creates an extremely sticky composition that sticks to the underside of the hoof WITHOUT WRAPPING, enabling the composition to be applied in 25 seconds rather than the 25 minutes it would take to mix a solution with all the ingredients and then wrapping the hoof with a diaper, vet wrap and duct tape to keep everything in place.
    Type: Application
    Filed: November 16, 2011
    Publication date: May 16, 2013
    Inventor: Ashley Kehoe
  • Publication number: 20130108683
    Abstract: The present invention provides compositions and methods for treating deep partial thickness or full thickness wounds or injuries. The present invention also provides compositions and methods for promoting healing and regeneration of impaired or damaged tissue at a site of such partial thickness or full thickness wounds or injuries, as well as promoting vascularization and angiogenesis in regenerating and/or supportive tissue at such sites.
    Type: Application
    Filed: October 24, 2012
    Publication date: May 2, 2013
    Applicant: BIOMIMETIC THERAPEUTICS, INC.
    Inventor: BioMimetic Therapeutics, Inc.
  • Publication number: 20130084272
    Abstract: The present invention relates to compositions, kits and methods for the administration of compositions and kits for supplementation with twelve carbon chain fatty acids or twelve carbon chain acylglycerols; and specifically for the supplementation with twelve carbon chain fatty acids such as lauric acid and twelve carbon chain acylglycerols such as monolaurin; and specifically for the co-supplementation with other vitamins, minerals and nutrients.
    Type: Application
    Filed: September 29, 2011
    Publication date: April 4, 2013
    Inventors: Philippe PERRIN, Guillaume HERRY, Cecile BOYER-JOUBERT
  • Patent number: 8404281
    Abstract: Nanoparticles comprising T3 and their use in treating, e.g., cardiac conditions, for example cardiac arrest, are provided. Such nanoparticles provide improved delivery of T3 and allow for acute treatment and optionally for sustained release of T3 in a patient.
    Type: Grant
    Filed: June 8, 2010
    Date of Patent: March 26, 2013
    Assignee: Avant Garde Therapeutics & Technologies LLC
    Inventors: Leo Rubin, Shaker Mousa
  • Publication number: 20130064809
    Abstract: A composition for prophylactic and/or therapeutic medicinal applications, or plant protection applications, in particular for the control of microorganisms, either planktonic or organized in biofilms. The composition includes at least one ion selected from hypohalite, at least one compound selected from lactoferrin, lactoferrin peptide, lysozyme, immunoglobulins or a combination thereof, optionally hypothiocyanite, and optionally at least one growth factor.
    Type: Application
    Filed: August 6, 2012
    Publication date: March 14, 2013
    Inventor: Jean-Paul PERRAUDIN
  • Publication number: 20130052278
    Abstract: The present disclosure provides a rapidly disintegrating orally administrable powder. The powder may include an active ingredient such as a dietary supplement. Methods of using the same are also provided herein.
    Type: Application
    Filed: March 10, 2011
    Publication date: February 28, 2013
    Applicant: RICH VITAMINS LLC
    Inventors: Hallie N. Rich, Michelle G. Cannon
  • Publication number: 20130045183
    Abstract: The present disclosure relates to non-acidic extracts or fractions selected from a Boswellia low polar gum resin extract fraction (BLPRE), a Boswellia volatile oil fraction (BVOIL), and a Boswellia oil fraction (BOIL) and their compositions. BLPRE, BOIL, and BVOIL are each derived from the gum resin of a Boswellia species. These compositions are useful for improving mental condition, enhancing brain functions such as cognition, memory, learning, communication and brain health, for treating impaired memory, and for preventing, control or treating memory and cognition related disorders/diseases. Additionally, BOIL, BVOIL, and mixtures of BOIL and BVOIL are useful for enhancing the bioavailability of a biological agent.
    Type: Application
    Filed: September 14, 2012
    Publication date: February 21, 2013
    Applicant: LAILA NUTRACEUTICALS
    Inventors: Ganga Raju GOKARAJU, Rama Raju GOKARAJU, Venkata Kanaka Ranga Raju GOKARAJU, Trimurtulu GOLAKOTI, Kiran BHUPATHIRAJU, Venkata Krishna Raju ALLURI
  • Patent number: 8377482
    Abstract: The invention discloses a trace element solution, which comprises at least one metal selected from the group comprising selenium, copper, zinc, manganese and chromium; and at least one component selected from the group comprising a vitamin, a vaccine, a growth stimulant, a dewormer, iron dextran, an antibiotic and a synchronization preparation. The synchronization preparation is a combination of injectable hormonal preparations, inplantable hormonal preparations, intravaginal hormonal preparation and other slow release hormonal preparation. The antibiotics include oral, injectable and implantable theurapeutic remedies. The vaccine includes antigens and a combination of antigens and adjuvents. The growth stimulants include zeranol, estradiol, testosterone, progesterone and trenbolone acetate. The dewormer includes macrocydic lactones, leramizoles, benzimidazoles and salicylanilides. The macrocydic lactones include doramectin, ivermectin, abamectin and moxidectin.
    Type: Grant
    Filed: September 7, 2005
    Date of Patent: February 19, 2013
    Assignee: Warburton Technology Limited
    Inventors: Robert N. Laurie, William A. Smith
  • Publication number: 20130039968
    Abstract: The invention provides a novel method of generating fabrics with outstanding antitoxic properties. The antitoxic properties are imparted to the fabric by introducing an active agent such as an antimicrobial or antiviral agent to the fabric. The active agent may be introduced into the fabric at multiple stages of the manufacturing process. For nonwoven fabrics, the active agent can be introduced during web formation and/or during post-processing steps. The fabrics produced in accordance with the present invention have widespread utility. For instance, they can be used as wound dressings, gowns, drapes, air filters, protective clothing and wipes.
    Type: Application
    Filed: February 22, 2011
    Publication date: February 14, 2013
    Applicant: TRIOMED INNOVATIONS CORP.
    Inventors: Pierre Jean Messier, David Ohayon
  • Publication number: 20130039953
    Abstract: A method for treating a surface with a therapeutic agent is disclosed. The method comprises precipitating a therapeutic agent from a hydrophilic polymeric base layer with which the therapeutic agent has been complexed, to form a layer comprising microparticles of the therapeutic agent on the hydrophilic polymeric base layer, the hydrophilic polymeric base layer being grafted to the surface. Devices comprising a surface having a hydrophilic polymeric base layer comprising a hydrophilic polymer grafted to the surface and a layer comprising microparticles of a therapeutic agent disposed on and complexed with the hydrophilic polymeric base layer are also disclosed.
    Type: Application
    Filed: July 6, 2012
    Publication date: February 14, 2013
    Applicant: Covalon Technologies
    Inventors: Vyacheslav Dudnyk, Valerio DiTizio
  • Publication number: 20130011490
    Abstract: This invention relates to a “high lower alcohol content” (>40% v/v of a C1-4 alcohol) liquid composition able to be dispensed as a stable foam with the use of non-propellant foam dispensing devices from non-pressurized containers. The liquid compositions comprise an alcohol, C1-4 (>40% v/v), a silicone-based surfactant of at least 0.001% by weight to prepare a foamable composition, 0-10% w/w of additional minor components added to obtain the desired performance (a foamable composition), and the balance being purified water. The compositions may include emulsifier-emollients and moisturizers, secondary surfactants, foam stabilizers, fragrances, antimicrobial agents, other type of medicinal ingredients, and the like ingredients or additives or combinations thereof commonly added to alcohol gels or foams, aerosol compositions or to toiletries, cosmetics, pharmaceuticals and the like.
    Type: Application
    Filed: September 10, 2012
    Publication date: January 10, 2013
    Applicant: DEB WORLDWIDE HEALTHCARE INC.
    Inventors: Maria Teresa Fernandez de Castro, Bruce Michael Koivisto, Francisco Munoz
  • Publication number: 20130004477
    Abstract: This invention provides compositions and methods for treating inflammation related diseases. Particularly, the present invention provides methods and compositions of administering thiocyanate to treat inflammation related diseases, such as cystic fibrosis, lung disease, lung cancer, asthma, bronchitis, pancreatic disease, digestive track disease, diabetes, neurological disorder, cardio-vascular disease, atherosclerosis, arthritis, nephritis, or stroke, and neurological disorders such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, or autism. The invention provides the use of thiocyanate to diagnose inflammation related diseases.
    Type: Application
    Filed: October 22, 2010
    Publication date: January 3, 2013
    Inventors: Zhe Lu, Yanping Xu
  • Publication number: 20120308670
    Abstract: A topical medicament for the treatment of psoriasis, comprising: chia oil, metallic iodine, virgin wax, a variety of oils of animal and plant origin, camphor, chlorophyll and benzoic acid, in a pharmaceutically acceptable emollient excipient base.
    Type: Application
    Filed: August 7, 2009
    Publication date: December 6, 2012
    Inventor: Ramon Efrain Vazquez Lipi
  • Publication number: 20120308669
    Abstract: A confection, such as chocolate, can be formulated to include naturally occurring amino acids and/or herbal extracts and/or plant extracts incorporated therein. The formulation allows a consumer to relieve health issues in a convenient, enjoyable manner. By incorporating the appropriate amino acids/herbal and plant extracts into a chocolate candy form, the confections can be formulated to provide relief of various ailments, such as insomnia, fatigue, PMS, difficulty concentrating and the like.
    Type: Application
    Filed: May 31, 2012
    Publication date: December 6, 2012
    Inventors: Gerald Zachary Smith, JR., Catherine Corbett Smith
  • Patent number: 8323703
    Abstract: This discovery is storable, pre-nascent iodine that activates and: produces nascent iodine over a two-to-three-hour period within the body when diluted in water and consumed. The iodine is in a low concentration in a tincture of grain alcohol. A quantity of tincture is submerged in a glass container in an electrolytic bath between two electrodes and subjected to a specific amperage for a period of time. This action causes the diatomic bond of the iodine molecule to be broken with the iodine atom receiving excitation energy from the magnetic field. When diluted and consumed into the body, the nascent iodine is able to produce significant beneficial effects in the body.
    Type: Grant
    Filed: September 5, 2006
    Date of Patent: December 4, 2012
    Inventor: John Staley Brookshire
  • Patent number: 8303994
    Abstract: A method for killing or substantially eradicating a pathogen in the upper respiratory tract of a mammal is disclosed. The method comprises generating molecular iodine (I2) in situ using an oxidant-reductant reaction with a minimum concentration of at least about 25 ppm of I2 and I2 comprises at least 40% of the total iodine atoms. A method for inhibiting superantigens using molecular iodine is also disclosed.
    Type: Grant
    Filed: June 22, 2006
    Date of Patent: November 6, 2012
    Inventors: Jack Howard Kessler, James Carlton Richards
  • Publication number: 20120276183
    Abstract: An absorbent product intended particularly for use as a wound dressing comprises an admixture of carboxymethyl chitosan and chitosan wherein the chitosan incorporates at least one antimicrobial agent. Absorbency is provided by the carboxymethyl chitosan and antimicrobial properties by the antimicrobial agent incorporated in the chitosan.
    Type: Application
    Filed: December 23, 2010
    Publication date: November 1, 2012
    Inventor: Colin Bradford
  • Patent number: 8298582
    Abstract: A polysaccharide-based solid material including, in its mass, at least one active agent having bactericidal, fungal, insecticidal and/or flame-retardant properties, and at least one complexing agent and/or at least one polymeric matrix having a complexing agent. The active agent includes at least one compound selected from the group including boron, silica, aluminum, phosphorus, iodine, derivatives thereof, aluminosilicate derivatives, and mixtures thereof. The solid material is characterized by an improved stability and by reduced environmental impact, and makes it possible to prepare materials based on wood particles and woods having a particular resistance against environmental attacks such as moisture.
    Type: Grant
    Filed: March 28, 2007
    Date of Patent: October 30, 2012
    Assignee: Hydro-Quebec
    Inventors: Louis Gastonguay, Michel Perrier, Paul-Étienne Harvey, Jean-François Labrecque, Michel Robitaille, André Besner